In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

By Anna Więckowska, N. Zein, L. Yerian, A. Rocio Lopez, A. McCullough, A. Feldstein. Hepatology, 2006

697 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology, Surgery

View Paper: https://www.semanticscholar.org/paper/f6639849bc9020dcf8c469c15bbfe7a1f32a3302

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Z. Younossi
2. A. Sanyal
3. K. Cusi
4. E. Brunt
5. J. Lavine
6. A. Diehl
7. N. Chalasani
8. C. Day

In Hepatology

1. Z. Younossi
2. K. Cusi
3. A. Sanyal
4. E. Brunt
5. A. Diehl
6. C. Day
7. M. Rinella
8. J. Clark

Citations in the corpus

• Nonalcoholic fatty liver disease: pathology and pathogenesis. (2010, background): “In NASH, apoptosis correlates with other above-described components of disease inflammatory activity and fibrosis (32, 134).”
• The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (2012, result): “, measured CK18 fragments in plasma that had been obtained from 44 consecutive patients with suspected NAFLD at the time of liver biopsy, and correlated the findings with hepatic immunohistochemistry data.(70) Plasma CK18 fragments were markedly increased in patients with NASH compared with patients”
• Non-alcoholic fatty liver disease: the mist gradually clears. (2008, background): “apoptosis) have recently been shown to accurately predict the presence of NASH in a small pilot study [55].”